-
Nestlé to Open Health Science Subsidiary and Research Institute
Nestlé, the global food and health products company based in Switzerland, announced today the creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences to expand the company’s industrial presence in nutrition and wellness. Nestlé says the two new organizations — one an operating division and the other an R&D center —…
-
Study: Tactile Signals Can Give Directions to Drivers
A new study finds drivers talking on cell phones and not hearing spoken instructions from a passenger or navigation system, can still get directions from devices mounted on the steering wheel. Nate Medeiros-Ward, a psychology doctoral student at University of Utah in Salt Lake City will present the findings tomorrow at the annual meeting of…
-
U.K. Partnership to Research TB Testing Methods
A collaboration between the National Physical Laboratory (NPL), the U.K.’s national measurement institute in Teddington, England and Orla Protein Technologies, a biotech company in Newcastle upon Tyne, England has been awarded £91,000 ($US 144,000) by the U.K. Technology Strategy Board to investigate improved methods for the detection of tuberculosis (TB). The U.S. Centers for Disease…
-
Trial Shows Positive Results for Hodgkin Lymphoma Drug
Seattle Genetics Inc., a biotech company in Bothell, Washington, and and Millennium, a developer of cancer drugs in Cambridge, Massachusetts, today released positive top-line results from a trial of their drug brentuximab vedotin. The drug is antibody-drug conjugate that works like an antibody carrying molecules toxic to cancer cells, targeted to CD30, a marker for…
-
Flywheel Developer Awarded ARPA-E Contract
Beacon Power Corporation, a developer of energy storage systems and services in Tyngsboro, Massachusetts, signed a contract with the U.S. Department of Energy’s Advanced Research Projects Agency – Energy (ARPA-E) to develop components of a more advanced flywheel energy storage system over a two-year period. Beacon Power says the contract is valued at $2.8 million.…
-
FDA Gives Muscular Dystrophy Therapy Orphan Drug Status
Amsterdam Molecular Therapeutics (AMT), a biotechnology company in the Netherlands doing work in human gene therapy, said today that the U.S. Food and Drug Administration (FDA) has designated its gene therapy for Duchenne muscular dystrophy (DMD) as an orphan drug. In October 2009, a committee the European Medicines Agency also granted the therapy, known as…
-
Water Purification Technology Launched Based on Rare Earths
Molycorp Minerals Inc., a producer of rare earths in Greenwood Village, Colorado, says it has launched of a new rare earth-based water purification technology called Xsorbx. Rare earths are a collection of mineral elements, such as cerium and lanthanum, used in advanced and strategic manufacturing products — e.g. electric car batteries, flat-screen TVs, and wind…
-
NRC Report: Biometric Technology “Inherently Fallible”
Biometric systems — designed to recognize individuals based on biological and behavioral traits such as fingerprints, palm prints, or voice or face recognition — are “inherently fallible,” says a new report by the National Research Council (NRC). In addition, says the report, no single biological and behavioral trait has been identified that is stable and…
-
Dana-Farber, Sanofi-aventis Partner on Cancer Research
Dana-Farber Cancer Institute’s Belfer Institute of Applied Cancer Science in Boston, Massachusetts and Sanofi-aventis, a global pharmaceutical company headquartered in Paris have struck a collaboration and license option agreement to identify and validate new oncology targets for further discovery and development by Sanofi-aventis. Dana-Farber’s Belfer Institute and Sanofi-aventis scientists will work together on discovering new…
-
NIH Foundation, Eli Lilly Launch US-Russia Science Partnership
The Foundation for the National Institutes of Health (FNIH) in Bethesda, Maryland and Eli Lilly and Company in Indianapolis, Indiana have started a U.S.–Russia Forum in Health Sciences to encourage collaboration on shared priorities in health related research. FNIH is establishing the forum with a $1.3 million grant from Eli Lilly as the founding private…